Dr. John Jude Kruse, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1520 Gause Blvd, Slidell, LA 70458 Phone: 985-646-0945 Fax: 985-643-8510 |
Joseph M Epps, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1051 Gause Blvd, Suite 410, Slidell, LA 70458 Phone: 985-280-1900 Fax: 985-280-1905 |
Amilcar J E Correa, M D Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2000 Old Spanish Trl, Suite 113, Slidell, LA 70458 Phone: 985-646-0970 Fax: 985-646-0971 |
News Archive
Jopari Solutions, the principal supplier of medical EDI services and connectivity networks to Providers and Payers in Property & Casualty markets, and Noble House, a software leader for billing and claims management for DME/HME, today announced a strategic partnership to advance medical billing and processing.
In a stride toward better health in later life, scientists reported today that resveratrol, the so-called "miracle molecule" found in red wine, might help improve mobility and prevent life-threatening falls among older people.
Elan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) today issued the following statement regarding the U.S. Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) as a treatment to improve walking in patients with multiple sclerosis (MS).
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has received affirmation by the Public Health Service of the U. S. Centers for Disease Control and Prevention and the Zentrale Kommission für die Biologische Sicherheit, the Central Commission for Biological Safety in Germany, that Advaxis strains, constructs and immunotherapies have been attenuated to the point that they are classified as non-pathogenic materials for handling and shipment.
Questions abound about what may happen if health care reform does happen.
› Verified 9 days ago